- Home
- NNBR vs IPSC Comparison
NNBR vs IPSC Comparison
Compare NNBR & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NNBR | IPSC |
|---|---|---|
| Founded | 1980 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.7M | 58.3M |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NNBR | IPSC |
|---|---|---|
| Price | $1.18 | $0.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 541.4K | ★ 1.3M |
| Earning Date | 10-29-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $424,005,000.00 | $113,337,000.00 |
| Revenue This Year | N/A | $1,590.09 |
| Revenue Next Year | $5.31 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4122.69 |
| 52 Week Low | $1.10 | $0.34 |
| 52 Week High | $4.67 | $1.19 |
Technical Indicators
Market Signals| Indicator | NNBR | IPSC |
|---|---|---|
| Relative Strength Index (RSI) | 35.66 | 84.41 |
| Support Level | $1.17 | $0.54 |
| Resistance Level | $1.24 | $0.62 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 20.03 | 88.79 |
Price Performance
Historical ComparisonAbout NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.